However, few individuals with newly diagnosed lung cancer engage in daily moderate-to-vigorous physical activity
AUROC estimate of four-marker protein panel plus PLCO<sub>m2012</sub> was 0.88 for risk prediction of lung cancer death
During 2014 to 2018, incidence continued to increase slowly for female breast cancer, remained stable for prostate cancer
Diagnostic shift from later-stage to earlier-stage disease may have implications for evaluation of treatments and mortality outcomes
Two-year trajectory of depression symptoms significantly linked to cancer survival; association for anxiety not significant
Higher case fatality rates found to be independent of demographic factors, such as age, sex, and race
Risk for dying from breast cancer remains elevated 15 years after initial diagnosis